• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发展中国家的乳腺癌:提高生存率的机会。

Breast cancer in developing countries: opportunities for improved survival.

机构信息

Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA.

出版信息

J Oncol. 2010;2010:595167. doi: 10.1155/2010/595167. Epub 2010 Dec 29.

DOI:10.1155/2010/595167
PMID:21253541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3021855/
Abstract

Breast cancer survival in the USA has continually improved over the last six decades and has largely been accredited to the use of mammography, advanced surgical procedures, and adjuvant therapies. Data indicate, however, that there were substantial improvements in survival in the USA even prior to these technological and diagnostic advances, suggesting important opportunities for early detection and treatment in low- and middle-income countries where these options are often unavailable and/or unaffordable. Thus, while continuing to strive for increased access to more advanced technology, improving survival in these settings should be more immediately achievable through increased awareness of breast cancer and of the potential for successful treatment, a high-quality primary care system without economic or cultural barriers to access, and a well-functioning referral system for basic surgical and hormonal treatment.

摘要

美国的乳腺癌存活率在过去六十年中持续提高,这主要归因于乳腺 X 线摄影术的使用、先进的外科手术和辅助治疗。然而,数据表明,即使在美国尚未采用这些技术和诊断方法之前,其存活率也有了实质性的提高,这表明在缺乏这些选择且往往无法获得或负担不起这些选择的低收入和中等收入国家,存在着进行早期检测和治疗的重要机会。因此,虽然我们继续努力争取更多机会获得更先进的技术,但通过提高对乳腺癌的认识以及对成功治疗的可能性的认识,在这些环境中提高存活率应该更容易实现,而无需克服经济或文化障碍即可获得高质量的初级保健系统,以及基本手术和激素治疗的良好转诊系统。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/364e/3021855/df748470a626/JO2010-595167.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/364e/3021855/df748470a626/JO2010-595167.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/364e/3021855/df748470a626/JO2010-595167.001.jpg

相似文献

1
Breast cancer in developing countries: opportunities for improved survival.发展中国家的乳腺癌:提高生存率的机会。
J Oncol. 2010;2010:595167. doi: 10.1155/2010/595167. Epub 2010 Dec 29.
2
Mammography screening: A major issue in medicine.乳腺 X 光筛查:医学中的一个重大问题。
Eur J Cancer. 2018 Feb;90:34-62. doi: 10.1016/j.ejca.2017.11.002. Epub 2017 Dec 20.
3
Overview of resistance to systemic therapy in patients with breast cancer.乳腺癌患者全身治疗耐药概述。
Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1.
4
Early detection and treatment strategies for breast cancer in low-income and upper middle-income countries: a modelling study.低收入和中上收入国家乳腺癌的早期检测和治疗策略:一项建模研究。
Lancet Glob Health. 2018 Aug;6(8):e885-e893. doi: 10.1016/S2214-109X(18)30257-2.
5
Surgical Services for Cancer Care癌症护理的外科服务
6
Improving early detection of breast cancer in sub-Saharan Africa: why mammography may not be the way forward.提高撒哈拉以南非洲地区乳腺癌的早期检测率:为何乳腺 X 线摄影术可能不是未来的发展方向。
Global Health. 2019 Jan 8;15(1):3. doi: 10.1186/s12992-018-0446-6.
7
Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010.优化中低收入国家乳腺癌管理:2010 年乳腺健康全球倡议共识执行摘要。
Lancet Oncol. 2011 Apr;12(4):387-98. doi: 10.1016/S1470-2045(11)70031-6.
8
Tuberculosis结核病
9
Improving outcomes in breast cancer for low and middle income countries.改善低收入和中等收入国家乳腺癌的治疗效果。
World J Surg. 2015 Mar;39(3):686-92. doi: 10.1007/s00268-014-2859-6.
10
Hormonal therapies for early breast cancer: systematic review and economic evaluation.早期乳腺癌的激素疗法:系统评价与经济学评估
Health Technol Assess. 2007 Jul;11(26):iii-iv, ix-xi, 1-134. doi: 10.3310/hta11260.

引用本文的文献

1
Global determinants of breast cancer mortality: a comprehensive meta-analysis of clinical, demographic, and lifestyle risk factors.乳腺癌死亡率的全球决定因素:临床、人口统计学和生活方式风险因素的综合荟萃分析
BMC Public Health. 2025 Aug 4;25(1):2640. doi: 10.1186/s12889-025-24036-w.
2
Evaluation of miR-27a-5p and miR-449a as potential serum biomarkers for breast cancer: a combined bioinformatics and experimental study.评估miR-27a-5p和miR-449a作为乳腺癌潜在血清生物标志物:一项生物信息学与实验相结合的研究
Mol Biol Rep. 2025 Jun 13;52(1):590. doi: 10.1007/s11033-025-10705-x.
3
Chemical Nose-Based Non-Invasive Detection of Breast Cancer Using Exhaled Breath.

本文引用的文献

1
Breast cancer: surgery at the South egypt cancer institute.乳腺癌:在埃及南部癌症研究所进行的手术。
Cancers (Basel). 2010 Sep 30;2(4):1771-8. doi: 10.3390/cancers2041771.
2
Can we treat cancer for a dollar a day? Guidelines for low-income countries.我们能用每天一美元的成本治疗癌症吗?低收入国家指南。
N Engl J Med. 2010 Aug 26;363(9):801-3. doi: 10.1056/NEJMp1002812.
3
Expansion of cancer care and control in countries of low and middle income: a call to action.在中低收入国家扩大癌症的防治工作:行动呼吁。
基于化学鼻的呼出气无创检测乳腺癌
Sensors (Basel). 2025 Mar 31;25(7):2210. doi: 10.3390/s25072210.
4
Pharmacophore modeling and molecular dynamics simulations to study the conformational stability of natural HER2 inhibitors in breast cancer therapy.用于研究天然HER2抑制剂在乳腺癌治疗中构象稳定性的药效团建模与分子动力学模拟
Mol Divers. 2025 Mar 24. doi: 10.1007/s11030-025-11165-y.
5
Design, Synthesis, and Mechanistic Anticancer Evaluation of New Pyrimidine-Tethered Compounds.新型嘧啶连接化合物的设计、合成及抗癌作用机制评估
Pharmaceuticals (Basel). 2025 Feb 19;18(2):270. doi: 10.3390/ph18020270.
6
Unveiling the role of SYNGR4 in breast cancer development: a novel target for immunotherapy.揭示SYNGR4在乳腺癌发展中的作用:免疫治疗的新靶点。
Front Oncol. 2025 Jan 20;14:1490073. doi: 10.3389/fonc.2024.1490073. eCollection 2024.
7
Breast cancer and its determinants in Ethiopia: a systematic review and meta-analysis.乳腺癌及其在埃塞俄比亚的决定因素:系统评价和荟萃分析。
BMJ Open. 2024 Nov 2;14(11):e080080. doi: 10.1136/bmjopen-2023-080080.
8
Core needle biopsy of breast tumours: comparison of diagnostic performance between surgery and radiology services at a national cancer centre in Latin America.乳腺肿瘤的粗针活检:拉丁美洲一家国家癌症中心外科与放射科诊断性能的比较
Ecancermedicalscience. 2024 Sep 13;18:1766. doi: 10.3332/ecancer.2024.1766. eCollection 2024.
9
Conditional probabilistic diffusion model driven synthetic radiogenomic applications in breast cancer.条件概率扩散模型驱动的乳腺癌合成放射基因组学应用。
PLoS Comput Biol. 2024 Oct 7;20(10):e1012490. doi: 10.1371/journal.pcbi.1012490. eCollection 2024 Oct.
10
Endophytic fungi: A future prospect for breast cancer therapeutics and drug development.内生真菌:乳腺癌治疗与药物开发的未来前景
Heliyon. 2024 Jul 4;10(13):e33995. doi: 10.1016/j.heliyon.2024.e33995. eCollection 2024 Jul 15.
Lancet. 2010 Oct 2;376(9747):1186-93. doi: 10.1016/S0140-6736(10)61152-X. Epub 2010 Aug 13.
4
Scaling up cancer diagnosis and treatment in developing countries: what can we learn from the HIV/AIDS epidemic?在发展中国家扩大癌症诊断与治疗:我们能从艾滋病毒/艾滋病疫情中学到什么?
Ann Oncol. 2010 Apr;21(4):680-682. doi: 10.1093/annonc/mdq055.
5
Breast health global initiative (BHGI) outline for program development in Latin America.拉美地区项目发展的乳腺健康全球倡议(BHGI)纲要。
Salud Publica Mex. 2009;51 Suppl 2:s309-15. doi: 10.1590/s0036-36342009000800022.
6
[The health care costs of breast cancer: the case of the Mexican Social Security Institute].[乳腺癌的医疗保健成本:以墨西哥社会保障机构为例]
Salud Publica Mex. 2009;51 Suppl 2:s286-95. doi: 10.1590/s0036-36342009000800019.
7
Delivering consensus from the Asian Oncology Summit 2009.传达2009年亚洲肿瘤学峰会的共识。
Lancet Oncol. 2009 Nov;10(11):1029-30. doi: 10.1016/S1470-2045(09)70324-9.
8
A road map to control malaria, tuberculosis, and human immunodeficiency virus/AIDS.控制疟疾、结核病和人类免疫缺陷病毒/艾滋病的路线图。
Arch Intern Med. 2009 Oct 12;169(18):1650-2. doi: 10.1001/archinternmed.2009.309.
9
Breast cancer in Mexico: a pressing priority.墨西哥的乳腺癌:一项紧迫的优先事项。
Reprod Health Matters. 2008 Nov;16(32):113-23. doi: 10.1016/S0968-8080(08)32414-8.
10
Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007.低收入和中等收入国家乳腺保健指南实施:2007年全球乳腺健康倡议全球峰会概述
Cancer. 2008 Oct 15;113(8 Suppl):2221-43. doi: 10.1002/cncr.23844.